# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://twitter.com/POTUS/status/1791152464617431389
https://subscriber.politicopro.com/article/2024/05/justice-department-poised-to-post-plans-for-marijuana-reclassification-00158...
CIBC analyst John Zamparo maintains Cronos Group (NASDAQ:CRON) with a Outperformer and raises the price target from $3 to $3.5.
https://www.marijuanamoment.net/dea-appears-to-question-marijuanas-medical-value-despite-rescheduling-recommendation/
Cronos Group Inc., (NASDAQ: CRON) a global cannabinoid company, has reported an increase in net revenue for the first quarter o...
Cronos Group (NASDAQ:CRON) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. The compan...
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announced on Tuesday that it's expanding its medical brand, PEACE NATURALS, in...